Section Arrow
ADGM.NASDAQ
- Adagio Medical Holdings Inc.
Quotes are at least 15-min delayed:2026/04/25 20:28 EDT
Regular Hours
Last
 1.51
0 (0.00%)
Day High 
1.58 
Prev. Close
1.51 
1-M High
1.69 
Volume 
60.26K 
Bid
1.46
Ask
1.54
Day Low
1.46 
Open
1.56 
1-M Low
1.06 
Market Cap 
33.54M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.47 
20-SMA 1.35 
50-SMA 1.16 
52-W High 2.582 
52-W Low 0.74 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.51/--
Enterprise Value
55.14M
Balance Sheet
Book Value Per Share
0.56
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ITOCiTonic Holdings Ltd.0.374+0.0744+24.83%-- 
BSXBoston Scientific Corp62.07-3.62-5.51%33.94PE
ABTAbbott Laboratories91.13-1.35-1.46%24.75PE
EWEdwards Lifesciences Corp84.15+4.43+5.56%45.45PE
PACBPacific Biosciences of California1.56-0.01-0.64%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLAis designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.